These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31006580)

  • 41. Peptide and recombinant immunotherapy.
    Larché M
    Immunol Allergy Clin North Am; 2011 May; 31(2):377-89, xi. PubMed ID: 21530826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allergen-specific immunotherapy. Present state and directions for the future.
    Malling HJ
    Allergy; 1999; 54 Suppl 50():30-3. PubMed ID: 10466034
    [No Abstract]   [Full Text] [Related]  

  • 43. Does allergen immunotherapy have a role in the treatment of bronchial asthma?
    Nelson HS
    Allergy Asthma Proc; 1997; 18(3):157-62. PubMed ID: 9194942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunotherapy of asthma: pro and contra].
    Müllner GF; Dahinden CA
    Ther Umsch; 1992 Oct; 49(10):674-7. PubMed ID: 1440435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of regulatory T cells by intranasal allergen immunotherapy in an experimental rat model of airway allergy.
    Moitra S; Datta A; Mondal S; Hazra I; Faruk SMO; Das PK; Basu AK; Tripathi SK; Chaudhuri S
    Int Immunopharmacol; 2017 Jun; 47():9-19. PubMed ID: 28349869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Birch pollen immunotherapy in mice: inhibition of Th2 inflammation is not sufficient to decrease airway hyper-reactivity.
    van Rijt LS; Gouveia L; Logiantara A; Canbaz D; Opstelten DJ; van der Kleij HP; van Ree R
    Int Arch Allergy Immunol; 2014; 165(2):128-39. PubMed ID: 25412572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study.
    Smith TR; Alexander C; Kay AB; Larché M; Robinson DS
    Allergy; 2004 Oct; 59(10):1097-101. PubMed ID: 15355469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical bystander effect exerted by allergen immunotherapy: a hypothesis.
    Ciprandi G
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):62-3. PubMed ID: 25781197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [SCIT helps with animal fur allergy: allergens on 4 legs].
    MMW Fortschr Med; 2011 Oct; 153(42):14-5. PubMed ID: 22053436
    [No Abstract]   [Full Text] [Related]  

  • 50. Subcutaneous immunotherapy using modified Phl p5a-derived peptides efficiently alleviates allergic asthma in mice.
    Hesse L; Feenstra R; Ambrosini M; de Jager WA; Petersen A; Vietor H; Unger WWJ; van Kooyk Y; Nawijn MC
    Allergy; 2019 Dec; 74(12):2495-2498. PubMed ID: 31124150
    [No Abstract]   [Full Text] [Related]  

  • 51. Allergen-specific sublingual immunotherapy for respiratory allergy.
    Passalacqua G; Canonica GW
    BioDrugs; 2001; 15(8):509-19. PubMed ID: 11543692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs).
    Klimek L; Pfaar O; Worm M
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1123-35. PubMed ID: 27191353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of human T-cell responses by allergen peptides.
    Larché M
    Immunology; 2001 Dec; 104(4):377-82. PubMed ID: 11899422
    [No Abstract]   [Full Text] [Related]  

  • 54. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
    Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
    Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indications for allergen immunotherapy during pregnancy.
    Metzger WJ
    Compr Ther; 1990 Mar; 16(3):17-26. PubMed ID: 2318030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Possibilities and limitations of hyposensitization treatment in airway allergies].
    Wahn U
    Ther Umsch; 1989 Sep; 46(9):625-32. PubMed ID: 2678573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Future advances of immunotherapy.
    Nelson HS
    Allergy Asthma Proc; 2001; 22(4):203-7. PubMed ID: 11552669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allergen-Specific Immunotherapy for Respiratory Allergy in Children: Unmet Needs and Future Goals.
    Comberiati P; Marseglia GL; Barberi S; Passalacqua G; Peroni DG
    J Allergy Clin Immunol Pract; 2017; 5(4):946-950. PubMed ID: 28389302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoregulation by targeting T cells in the treatment of allergy and asthma.
    Larché M
    Curr Opin Immunol; 2006 Dec; 18(6):745-50. PubMed ID: 17010586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.